Q14896 (MYPC3_HUMAN) Reviewed, UniProtKB/Swiss-Prot

Names and origin

Protein names

Recommended name:
Myosin-binding protein C, cardiac-type
Short name=Cardiac MyBP-C

Alternative name(s):
C-protein, cardiac muscle isoform

Gene names

Name:

MYBPC3

Organism

Homo sapiens (Human) [Reference proteome]

Taxonomic identifier

9606 [NCBI]

Taxonomic lineage

cellular organisms › Eukaryota › Opisthokonta › Metazoa › Eumetazoa › Bilateria › Deuterostomia › Chordata › Craniata › Vertebrata › Gnathostomata › Teleostomi › Euteleostomi › Sarcopterygii › Dipnotetrapodomorpha › Tetrapoda › Amniota › Mammalia › Theria › Eutheria › Boreoeutheria › Euarchontoglires › Primates › Haplorrhini › Simiiformes › Catarrhini › Hominoidea › Hominidae › Homininae › Homo

Protein attributes

Sequence length	1274 AA.
Sequence status	Complete.
Protein existence	Evidence at protein level

General annotation (Comments)

Function	Thick filament-associated protein located in the crossbridge region of vertebrate striated muscle a bands. In vitro it binds MHC, F-actin and native thin filaments, and modifies the activity of actin-activated myosin ATPase. It may modulate muscle contraction or may play a more structural role.
Post-translational modification	Substrate for phosphorylation by PKA and PKC. Reversible phosphorylation appears to modulate contraction By similarity.
Involvement in disease	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. Note: The disease is caused by mutations affecting the gene represented in this entry. Ref.1 Ref.2 Ref.3 Ref.14 Ref.15 Ref.17 Ref.18 Ref.19 Ref.20 Ref.21 Ref.22 Ref.24 Ref.25 Ref.26 Ref.27 Ref.28 Ref.29 Ref.31 Ref.32 Ref.34 Cardiomyopathy, dilated 1MM (CMD1MM) [MIM:615396]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. Note: The disease is caused by mutations affecting the gene represented in this entry. Left ventricular non-compaction 10 (LVNC10) [MIM:615396]: A disease due to an arrest of myocardial morphogenesis. It is characterized by a hypertrophic left ventricle with deep trabeculations and with poor systolic function, with or without associated left ventricular dilation. In some cases, it is associated with other congenital heart anomalies. Note: The disease is caused by mutations affecting the gene represented in this entry.
Sequence similarities	Belongs to the immunoglobulin superfamily. MyBP family. Contains 3 fibronectin type-III domains. Contains 7 Ig-like C2-type (immunoglobulin-like) domains.

Ontologies

Keywords
Biological process	Cell adhesion
Cellular component	Thick filament
Coding sequence diversity	Alternative splicing Polymorphism
Disease	Cardiomyopathy Disease mutation
Domain	Immunoglobulin domain Repeat
Ligand	Actin-binding Metal-binding Zinc
Molecular function	Muscle protein
PTM	Acetylation Disulfide bond Phosphoprotein
Technical term	3D-structure Complete proteome Reference proteome
Gene Ontology (GO)
Biological_process	cardiac muscle contraction Inferred from sequence or structural similarity. Source: BHF-UCL cell adhesion Inferred from electronic annotation. Source: UniProtKB-KW muscle filament sliding Traceable author statement. Source: Reactome myosin filament assembly Inferred from electronic annotation. Source: Ensembl regulation of heart rate Inferred from electronic annotation. Source: Ensembl regulation of muscle filament sliding Inferred from sequence or structural similarity. Source: BHF-UCL regulation of striated muscle contraction Inferred from sequence or structural similarity. Source: BHF-UCL sarcomere organization Inferred from electronic annotation. Source: Ensembl ventricular cardiac muscle tissue morphogenesis Inferred from mutant phenotype PubMed 16754800. Source: BHF-UCL
Cellular_component	C zone Non-traceable author statement PubMed 15166115. Source: BHF-UCL cytosol Traceable author statement. Source: Reactome striated muscle myosin thick filament Inferred from direct assay PubMed 10024460. Source: BHF-UCL
Molecular_function	ATPase activator activity Inferred from sequence or structural similarity. Source: BHF-UCL metal ion binding Inferred from electronic annotation. Source: UniProtKB-KW myosin binding Inferred from direct assay PubMed 10024460. Source: BHF-UCL structural constituent of muscle Inferred from mutant phenotype PubMed 7493025. Source: BHF-UCL titin binding Non-traceable author statement PubMed 7493025. Source: BHF-UCL
Complete GO annotation...

Binary interactions

With	Entry	#Exp.	IntAct	Notes
itself		2	EBI-704176,EBI-704176

Alternative products

This entry describes 2 isoforms produced by alternative splicing. [Align] [Select]

Isoform 1 (identifier: Q14896-1)

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.

Isoform 2 (identifier: Q14896-2)

The sequence of this isoform differs from the canonical sequence as follows:
     408-409: SK → R

Sequence annotation (Features)

Feature key

Position(s)

Length

Description

Graphical view

Feature identifier

Molecule processing

Chain

1 – 1274

1274

Myosin-binding protein C, cardiac-type

PRO_0000072693

Regions

Domain

153 – 256

104

Ig-like C2-type 1

Domain

362 – 452

91

Ig-like C2-type 2

Domain

453 – 543

91

Ig-like C2-type 3

Domain

544 – 633

90

Ig-like C2-type 4

Domain

645 – 771

127

Ig-like C2-type 5

Domain

774 – 870

97

Fibronectin type-III 1

Domain

872 – 967

96

Fibronectin type-III 2

Domain

971 – 1065

95

Ig-like C2-type 6

Domain

1068 – 1163

96

Fibronectin type-III 3

Domain

1181 – 1274

94

Ig-like C2-type 7

Compositional bias

102 – 152

51

Pro-rich

Sites

Metal binding

208

1

Zinc

Metal binding

210

1

Zinc

Metal binding

223

1

Zinc

Metal binding

225

1

Zinc

Amino acid modifications

Modified residue

1

1

N-acetylmethionine By similarity

Modified residue

275

1

Phosphoserine; by PKA and PKC By similarity

Modified residue

284

1

Phosphoserine; by PKA and PKC By similarity

Modified residue

304

1

Phosphoserine; by PKA and PKC By similarity

Disulfide bond

436 ↔ 443

Potential

Natural variations

Alternative sequence

408 – 409

2

SK → R in isoform 2.

VSP_047141

Natural variant

5

1

G → R in CMH4. Ref.29

VAR_029390

Natural variant

59

1

T → A in CMH4. Ref.20

VAR_029391

Natural variant

158

1

V → M. Ref.4 Ref.29 Ref.34
Corresponds to variant rs3729986 [ dbSNP | Ensembl ].

VAR_020085

Natural variant

161

1

P → S in CMH4. Ref.25

VAR_029392

Natural variant

189

1

V → I. Ref.4
Corresponds to variant rs11570052 [ dbSNP | Ensembl ].

VAR_020568

Natural variant

219

1

V → L in CMH4. Ref.29

VAR_029393

Natural variant

228

1

D → N in CMH4. Ref.28

VAR_029394

Natural variant

236

1

S → G. Ref.4 Ref.19 Ref.24 Ref.29 Ref.30 Ref.34
Corresponds to variant rs3729989 [ dbSNP | Ensembl ].

VAR_020086

Natural variant

237

1

Y → S in CMH4. Ref.27

VAR_029395

Natural variant

256

1

V → I in CMH4. Ref.29

VAR_029396

Natural variant

257

1

H → P in CMH4. Ref.22

VAR_019889

Natural variant

258

1

E → K in CMH4. Ref.21 Ref.22 Ref.24 Ref.25 Ref.28 Ref.29 Ref.31

VAR_019890

Natural variant

263

1

G → R in CMH4. Ref.31

VAR_042740

Natural variant

272

1

R → C in CMH4.

VAR_070449

Natural variant

273

1

R → H in CMH4. Ref.32

VAR_042741

Natural variant

278

1

G → E in CMH4. Ref.22 Ref.34
Corresponds to variant rs147315081 [ dbSNP | Ensembl ].

VAR_019891

Natural variant

279

1

G → A in CMH4. Ref.22

VAR_019892

Natural variant

281

1

R → Q. Ref.4
Corresponds to variant rs11570060 [ dbSNP | Ensembl ].

VAR_020569

Natural variant

282

1

R → W in CMH4. Ref.18 Ref.24

VAR_029397

Natural variant

326

1

R → Q. Ref.17 Ref.19 Ref.20 Ref.22 Ref.24 Ref.27 Ref.29 Ref.32 Ref.34
Corresponds to variant rs34580776 [ dbSNP | Ensembl ].

VAR_019893

Natural variant

336

1

I → V in CMH4.

VAR_070450

Natural variant

352

1

L → P in CMH4. Ref.22

VAR_019894

Natural variant

382

1

R → W. Ref.4 Ref.29
Corresponds to variant rs11570076 [ dbSNP | Ensembl ].

VAR_020570

Natural variant

383

1

L → V. Ref.4
Corresponds to variant rs11570077 [ dbSNP | Ensembl ].

VAR_020571

Natural variant

416

1

G → S. Ref.29

VAR_029398

Natural variant

417

1

A → S in CMH4. Ref.31

VAR_042742

Natural variant

451

1

E → Q in CMH4. Ref.3

VAR_027879

Natural variant

458

1

R → H in CMH4. Ref.29

VAR_029399

Natural variant

490

1

G → R in CMH4, CMD1MM and LVNC10.

VAR_029400

Natural variant

490

1

G → V in CMH4.

VAR_070451

Natural variant

495

1

R → G in CMH4. Ref.34

VAR_045929

Natural variant

495

1

R → Q in CMH4. Ref.3 Ref.17 Ref.29

VAR_027880

Natural variant

502

1

R → Q in CMH4. Ref.3 Ref.34

VAR_027881

Natural variant

502

1

R → W in CMH4. Ref.22 Ref.29 Ref.32 Ref.34

VAR_019895

Natural variant

504

1

Missing in CMH4. Ref.22

VAR_019896

Natural variant

507

1

G → R in CMH4. Ref.18 Ref.24 Ref.29
Corresponds to variant rs35736435 [ dbSNP | Ensembl ].

VAR_029401

Natural variant

522

1

A → T. Ref.4
Corresponds to variant rs11570082 [ dbSNP | Ensembl ].

VAR_020573

Natural variant

523

1

G → W in CMH4. Ref.24

VAR_029402

Natural variant

542

1

E → Q in CMH4. Ref.2 Ref.22 Ref.29 Ref.32

VAR_003917

Natural variant

545

1

L → M. Ref.29

VAR_029403

Natural variant

566

1

C → R in CMH4. Ref.18 Ref.24

VAR_029404

Natural variant

604

1

D → V in CMH4. Ref.29

VAR_029405

Natural variant

605

1

D → N in CMH4; pathogenicity remains to be determined. Ref.25 Ref.29 Ref.34

VAR_029406

Natural variant

608

1

P → L in CMH4. Ref.29

VAR_029407

Natural variant

654

1

R → H in CMH4; as well folded and stable as the wild-type. Ref.9 Ref.15
Corresponds to variant rs1800565 [ dbSNP | Ensembl ].

VAR_003918

Natural variant

668

1

R → H in CMH4. Ref.27

VAR_029408

Natural variant

668

1

R → P in CMH4. Ref.24

VAR_029409

Natural variant

669

1

L → H in CMH4. Ref.31

VAR_042743

Natural variant

733

1

R → C in CMH4. Ref.29

VAR_029410

Natural variant

755

1

N → K in CMH4; destabilizes the structure of Ig-like C2-type domain 5. Ref.9 Ref.14

VAR_003919

Natural variant

759

1

E → D in CMH4. Ref.31

VAR_042744

Natural variant

770

1

D → N in CMH4. Ref.29
Corresponds to variant rs36211723 [ dbSNP | Ensembl ].

VAR_029411

Natural variant

792

1

W → R in CMH4. Ref.29

VAR_029412

Natural variant

810

1

R → H in CMH4. Ref.21 Ref.29

VAR_029413

Natural variant

811

1

K → R in CMH4. Ref.22

VAR_019897

Natural variant

811

1

Missing in CMH4. Ref.29

VAR_029414

Natural variant

813

1

Missing in CMH4. Ref.28

VAR_029415

Natural variant

820

1

R → Q in CMH4. Ref.1 Ref.2 Ref.21 Ref.26
Corresponds to variant rs2856655 [ dbSNP | Ensembl ].

VAR_029416

Natural variant

833

1

A → T in CMH4 and CMD1MM.

VAR_029417

Natural variant

833

1

A → V in CMH4. Ref.4 Ref.22 Ref.24
Corresponds to variant rs3729952 [ dbSNP | Ensembl ].

VAR_019898

Natural variant

834

1

R → T in CMH4.

VAR_029418

Natural variant

834

1

R → W in CMH4; pathogenicity is uncertain. Ref.25

VAR_029419

Natural variant

873

1

P → H in CMH4. Ref.21

VAR_029420

Natural variant

873

1

P → L in LVNC10.

VAR_070452

Natural variant

896

1

V → M May act as a phenotype modifier in cardiomyopathy patients. Ref.16 Ref.22 Ref.27 Ref.29 Ref.34
Corresponds to variant rs35078470 [ dbSNP | Ensembl ].

VAR_019899

Natural variant

948

1

N → T in CMH4. Ref.19

VAR_029421

Natural variant

957

1

T → S in CMH4.

VAR_070453

Natural variant

958

1

T → I in CMH4.

VAR_070454

Natural variant

998

1

Q → E in CMH4; dbNP:11570112. Ref.4 Ref.29
Corresponds to variant rs11570112 [ dbSNP | Ensembl ].

VAR_020574

Natural variant

998

1

Q → R in CMH4. Ref.29

VAR_029422

Natural variant

1002

1

R → Q in CMH4. Ref.20

VAR_029423

Natural variant

1002

1

R → W. Ref.34
Corresponds to variant rs3729799 [ dbSNP | Ensembl ].

VAR_029424

Natural variant

1003

1

P → Q in CMH4.

VAR_029425

Natural variant

1028

1

T → S in CMH4. Ref.34

VAR_045930

Natural variant

1048

1

R → C. Ref.4
Corresponds to variant rs11570113 [ dbSNP | Ensembl ].

VAR_020575

Natural variant

1113

1

F → I in CMH4. Ref.29

VAR_029426

Natural variant

1115

1

V → I in CMH4. Ref.18 Ref.24

VAR_029427

Natural variant

1131

1

I → T in CMH4; unknown pathological significance.

VAR_029428

Natural variant

1155

1

Missing in CMH4.

VAR_029429

Natural variant

1194

1

A → T in CMH4. Ref.22

VAR_019900

Natural variant

1248

1

G → R in CMH4. Ref.34

VAR_045931

Natural variant

1255

1

A → T in CMH4. Ref.22

VAR_019901

Natural variant

1264

1

C → F in CMD1MM.

VAR_070455

Experimental info

Sequence conflict

248

1

D → E Ref.1

Sequence conflict

248

1

D → E Ref.2

Sequence conflict

302 – 303

2

RD → SS in AAR89909. Ref.4

Sequence conflict

536

1

A → R in CAA58882. Ref.1

Secondary structure

1

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

1274

Helix Strand Turn

Details...

Beta strand

19 – 22

4

Beta strand

27 – 32

6

Beta strand

34 – 37

4

Beta strand

41 – 43

3

Beta strand

45 – 49

5

Beta strand

56 – 60

5

Beta strand

63 – 70

8

Beta strand

77 – 83

7

Beta strand

86 – 95

10

Beta strand

156 – 159

4

Beta strand

164 – 167

4

Beta strand

172 – 179

8

Beta strand

184 – 186

3

Beta strand

188 – 193

6

Turn

194 – 196

3

Helix

199 – 202

4

Beta strand

207 – 214

8

Turn

215 – 218

4

Beta strand

219 – 226

8

Helix

231 – 233

3

Beta strand

235 – 242

8

Beta strand

247 – 257

11

Beta strand

650 – 652

3

Beta strand

658 – 665

8

Beta strand

670 – 672

3

Beta strand

675 – 677

3

Beta strand

680 – 686

7

Beta strand

722 – 724

3

Beta strand

726 – 730

5

Beta strand

733 – 737

5

Turn

743 – 745

3

Beta strand

747 – 754

8

Beta strand

759 – 768

10

Sequences

	Sequence		Length	Mass (Da)
	Isoform 1 [UniParc]. Last modified November 28, 2012. Version 4. Checksum: 4E5385C40085B796	FASTA	1,274	140,762
	10 20 30 40 50 60 MPEPGKKPVS AFSKKPRSVE VAAGSPAVFE AETERAGVKV RWQRGGSDIS ASNKYGLATE 70 80 90 100 110 120 GTRHTLTVRE VGPADQGSYA VIAGSSKVKF DLKVIEAEKA EPMLAPAPAP AEATGAPGEA 130 140 150 160 170 180 PAPAAELGES APSPKGSSSA ALNGPTPGAP DDPIGLFVMR PQDGEVTVGG SITFSARVAG 190 200 210 220 230 240 ASLLKPPVVK WFKGKWVDLS SKVGQHLQLH DSYDRASKVY LFELHITDAQ PAFTGSYRCE 250 260 270 280 290 300 VSTKDKFDCS NFNLTVHEAM GTGDLDLLSA FRRTSLAGGG RRISDSHEDT GILDFSSLLK 310 320 330 340 350 360 KRDSFRTPRD SKLEAPAEED VWEILRQAPP SEYERIAFQY GVTDLRGMLK RLKGMRRDEK 370 380 390 400 410 420 KSTAFQKKLE PAYQVSKGHK IRLTVELADH DAEVKWLKNG QEIQMSGSKY IFESIGAKRT 430 440 450 460 470 480 LTISQCSLAD DAAYQCVVGG EKCSTELFVK EPPVLITRPL EDQLVMVGQR VEFECEVSEE 490 500 510 520 530 540 GAQVKWLKDG VELTREETFK YRFKKDGQRH HLIINEAMLE DAGHYALCTS GGQALAELIV 550 560 570 580 590 600 QEKKLEVYQS IADLMVGAKD QAVFKCEVSD ENVRGVWLKN GKELVPDSRI KVSHIGRVHK 610 620 630 640 650 660 LTIDDVTPAD EADYSFVPEG FACNLSAKLH FMEVKIDFVP RQEPPKIHLD CPGRIPDTIV 670 680 690 700 710 720 VVAGNKLRLD VPISGDPAPT VIWQKAITQG NKAPARPAPD APEDTGDSDE WVFDKKLLCE 730 740 750 760 770 780 TEGRVRVETT KDRSIFTVEG AEKEDEGVYT VTVKNPVGED QVNLTVKVID VPDAPAAPKI 790 800 810 820 830 840 SNVGEDSCTV QWEPPAYDGG QPILGYILER KKKKSYRWMR LNFDLIQELS HEARRMIEGV 850 860 870 880 890 900 VYEMRVYAVN AIGMSRPSPA SQPFMPIGPP SEPTHLAVED VSDTTVSLKW RPPERVGAGG 910 920 930 940 950 960 LDGYSVEYCP EGCSEWVAAL QGLTEHTSIL VKDLPTGARL LFRVRAHNMA GPGAPVTTTE 970 980 990 1000 1010 1020 PVTVQEILQR PRLQLPRHLR QTIQKKVGEP VNLLIPFQGK PRPQVTWTKE GQPLAGEEVS 1030 1040 1050 1060 1070 1080 IRNSPTDTIL FIRAARRVHS GTYQVTVRIE NMEDKATLVL QVVDKPSPPQ DLRVTDAWGL 1090 1100 1110 1120 1130 1140 NVALEWKPPQ DVGNTELWGY TVQKADKKTM EWFTVLEHYR RTHCVVPELI IGNGYYFRVF 1150 1160 1170 1180 1190 1200 SQNMVGFSDR AATTKEPVFI PRPGITYEPP NYKALDFSEA PSFTQPLVNR SVIAGYTAML 1210 1220 1230 1240 1250 1260 CCAVRGSPKP KISWFKNGLD LGEDARFRMF SKQGVLTLEI RKPCPFDGGI YVCRATNLQG 1270 EARCECRLEV RVPQ
	Isoform 2 [UniParc]. Checksum: A23FC20A513F4920	FASTA	1,273	140,703
	10 20 30 40 50 60 MPEPGKKPVS AFSKKPRSVE VAAGSPAVFE AETERAGVKV RWQRGGSDIS ASNKYGLATE 70 80 90 100 110 120 GTRHTLTVRE VGPADQGSYA VIAGSSKVKF DLKVIEAEKA EPMLAPAPAP AEATGAPGEA 130 140 150 160 170 180 PAPAAELGES APSPKGSSSA ALNGPTPGAP DDPIGLFVMR PQDGEVTVGG SITFSARVAG 190 200 210 220 230 240 ASLLKPPVVK WFKGKWVDLS SKVGQHLQLH DSYDRASKVY LFELHITDAQ PAFTGSYRCE 250 260 270 280 290 300 VSTKDKFDCS NFNLTVHEAM GTGDLDLLSA FRRTSLAGGG RRISDSHEDT GILDFSSLLK 310 320 330 340 350 360 KRDSFRTPRD SKLEAPAEED VWEILRQAPP SEYERIAFQY GVTDLRGMLK RLKGMRRDEK 370 380 390 400 410 420 KSTAFQKKLE PAYQVSKGHK IRLTVELADH DAEVKWLKNG QEIQMSGRYI FESIGAKRTL 430 440 450 460 470 480 TISQCSLADD AAYQCVVGGE KCSTELFVKE PPVLITRPLE DQLVMVGQRV EFECEVSEEG 490 500 510 520 530 540 AQVKWLKDGV ELTREETFKY RFKKDGQRHH LIINEAMLED AGHYALCTSG GQALAELIVQ 550 560 570 580 590 600 EKKLEVYQSI ADLMVGAKDQ AVFKCEVSDE NVRGVWLKNG KELVPDSRIK VSHIGRVHKL 610 620 630 640 650 660 TIDDVTPADE ADYSFVPEGF ACNLSAKLHF MEVKIDFVPR QEPPKIHLDC PGRIPDTIVV 670 680 690 700 710 720 VAGNKLRLDV PISGDPAPTV IWQKAITQGN KAPARPAPDA PEDTGDSDEW VFDKKLLCET 730 740 750 760 770 780 EGRVRVETTK DRSIFTVEGA EKEDEGVYTV TVKNPVGEDQ VNLTVKVIDV PDAPAAPKIS 790 800 810 820 830 840 NVGEDSCTVQ WEPPAYDGGQ PILGYILERK KKKSYRWMRL NFDLIQELSH EARRMIEGVV 850 860 870 880 890 900 YEMRVYAVNA IGMSRPSPAS QPFMPIGPPS EPTHLAVEDV SDTTVSLKWR PPERVGAGGL 910 920 930 940 950 960 DGYSVEYCPE GCSEWVAALQ GLTEHTSILV KDLPTGARLL FRVRAHNMAG PGAPVTTTEP 970 980 990 1000 1010 1020 VTVQEILQRP RLQLPRHLRQ TIQKKVGEPV NLLIPFQGKP RPQVTWTKEG QPLAGEEVSI 1030 1040 1050 1060 1070 1080 RNSPTDTILF IRAARRVHSG TYQVTVRIEN MEDKATLVLQ VVDKPSPPQD LRVTDAWGLN 1090 1100 1110 1120 1130 1140 VALEWKPPQD VGNTELWGYT VQKADKKTME WFTVLEHYRR THCVVPELII GNGYYFRVFS 1150 1160 1170 1180 1190 1200 QNMVGFSDRA ATTKEPVFIP RPGITYEPPN YKALDFSEAP SFTQPLVNRS VIAGYTAMLC 1210 1220 1230 1240 1250 1260 CAVRGSPKPK ISWFKNGLDL GEDARFRMFS KQGVLTLEIR KPCPFDGGIY VCRATNLQGE 1270 ARCECRLEVR VPQ

References

	« Hide 'large scale' referencesShow 'large scale' references »
[1]	"Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction?" Gautel M., Zuffardi O., Freiburg A., Labeit S. EMBO J. 14:1952-1960(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANT CMH4 GLN-820. Tissue: Heart.
[2]	"Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy." Carrier L., Bonne G., Bahrend E., Yu B., Richard P., Niel F., Hainque B., Cruaud C., Gary F., Labeit S., Bouhour J.-B., Dubourg O., Desnos M., Hagege A.A., Trent R.J., Komajda M., Fiszman M., Schwartz K. Circ. Res. 80:427-434(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS CMH4 GLN-542 AND GLN-820.
[3]	"Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy." Niimura H., Bachinski L.L., Sangwatanaroj S., Watkins H., Chudley A.E., McKenna W., Kristinsson A., Roberts R., Sole M., Maron B.J., Seidman J.G., Seidman C.E. N. Engl. J. Med. 338:1248-1257(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS CMH4 GLN-451; GLN-495 AND GLN-502.
[4]	NIEHS SNPs program Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS MET-158; ILE-189; GLY-236; GLN-281; TRP-382; VAL-383; THR-522; VAL-833; GLU-998 AND CYS-1048.
[5]	Rieder M.J., Bertucci C., Stanaway I.B., Johnson E.J., Swanson J.E., Siegel D.L., da Ponte S.H., Igartua C., Patterson K., Nickerson D.A. Submitted (NOV-2009) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
[6]	"Human chromosome 11 DNA sequence and analysis including novel gene identification." Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K., Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G. , Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S., Sakaki Y. Nature 440:497-500(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[7]	"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
[8]	"Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy." Bonne G., Carrier L., Bercovici J., Cruaud C., Richard P., Hainque B., Gautel M., Labeit S., James M., Beckmann J., Weissenbach J., Vosberg H.-P., Fiszman M., Komajda M., Schwartz K. Nat. Genet. 11:438-440(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 640-694.
[9]	"Structure, stability and dynamics of the central domain of cardiac myosin binding protein C (MyBP-C): implications for multidomain assembly and causes for cardiomyopathy." Idowu S.M., Gautel M., Perkins S.J., Pfuhl M. J. Mol. Biol. 329:745-761(2003) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 641-770, CHARACTERIZATION OF VARIANTS HIS-654 AND LYS-755.
[10]	"Sequence specific assignment of domain C1 of the N-terminal myosin-binding site of human cardiac myosin binding protein C (MyBP-C)." Ababou A., Zhou L., Gautel M., Pfuhl M. J. Biomol. NMR 29:431-432(2004) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 358-450, POTENTIAL DISULFIDE BOND.
[11]	"An investigation into the protonation states of the C1 domain of cardiac myosin-binding protein C." Fisher S.J., Helliwell J.R., Khurshid S., Govada L., Redwood C., Squire J.M., Chayen N.E. Acta Crystallogr. D 64:658-664(2008) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.3 ANGSTROMS) OF 151-258.
[12]	"Crystal structure of the C1 domain of cardiac myosin binding protein-C: implications for hypertrophic cardiomyopathy." Govada L., Carpenter L., da Fonseca P.C., Helliwell J.R., Rizkallah P., Flashman E., Chayen N.E., Redwood C., Squire J.M. J. Mol. Biol. 378:387-397(2008) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 151-258.
[13]	"Myosin binding protein C positioned to play a key role in regulation of muscle contraction: structure and interactions of domain C1." Ababou A., Rostkova E., Mistry S., Le Masurier C., Gautel M., Pfuhl M. J. Mol. Biol. 384:615-630(2008) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 151-260, ZINC-BINDING SITE.
[14]	"Molecular pathology of familial hypertrophic cardiomyopathy caused by mutations in the cardiac myosin binding protein C gene." Yu B., French J.A., Carrier L., Jeremy R.W., McTaggart D.R., Nicholson M.R., Hambly B., Semsarian C., Richmond D.R., Schwartz K., Trent R.J. J. Med. Genet. 35:205-210(1998) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT CMH4 LYS-755.
[15]	"Identification of a new missense mutation in MyBP-C associated with hypertrophic cardiomyopathy." Moolman-Smook J.C., Mayosi B., Brink P., Corfield V.A. J. Med. Genet. 35:253-254(1998) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT CMH4 HIS-654.
[16]	"The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: a unique profile of both independent and founder events." Moolman-Smook J.C., De Lange W.J., Bruwer E.C.D., Brink P.A., Corfield V.A. Am. J. Hum. Genet. 65:1308-1320(1999) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT MET-896.
[17]	"Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations." Maron B.J., Niimura H., Casey S.A., Soper M.K., Wright G.B., Seidman J.G., Seidman C.E. J. Am. Coll. Cardiol. 38:315-321(2001) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT CMH4 GLN-495, VARIANT GLN-326.
[18]	"Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy." Erdmann J., Raible J., Maki-Abadi J., Hummel M., Hammann J., Wollnik B., Frantz E., Fleck E., Hetzer R., Regitz-Zagrosek V. J. Am. Coll. Cardiol. 38:322-330(2001) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS CMH4 TRP-282; ARG-507; ARG-566 AND ILE-1115.
[19]	"Novel mutations in sarcomeric protein genes in dilated cardiomyopathy." Daehmlow S., Erdmann J., Knueppel T., Gille C., Froemmel C., Hummel M., Hetzer R., Regitz-Zagrosek V. Biochem. Biophys. Res. Commun. 298:116-120(2002) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT CMH4 THR-948, VARIANTS GLY-236 AND GLN-326.
[20]	"Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly." Niimura H., Patton K.K., McKenna W.J., Soults J., Maron B.J., Seidman J.G., Seidman C.E. Circulation 105:446-451(2002) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS CMH4 ALA-59 AND GLN-1002, VARIANT GLN-326.
[21]	"Hypertrophic cardiomyopathy: two homozygous cases with 'typical' hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy." Nanni L., Pieroni M., Chimenti C., Simionati B., Zimbello R., Maseri A., Frustaci A., Lanfranchi G. Biochem. Biophys. Res. Commun. 309:391-398(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS CMH4 LYS-258; HIS-810; GLN-820 AND HIS-873.
[22]	"Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy." Richard P., Charron P., Carrier L., Ledeuil C., Cheav T., Pichereau C., Benaiche A., Isnard R., Dubourg O., Burban M., Gueffet J.-P., Millaire A., Desnos M., Schwartz K., Hainque B., Komajda M. Circulation 107:2227-2232(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS CMH4 PRO-257; LYS-258; GLU-278; ALA-279; PRO-352; TRP-502; LYS-504 DEL; GLN-542; ARG-811; VAL-833; THR-1194 AND THR-1255, VARIANTS GLN-326 AND MET-896.
[23]	Erratum Richard P., Charron P., Carrier L., Ledeuil C., Cheav T., Pichereau C., Benaiche A., Isnard R., Dubourg O., Burban M., Gueffet J.-P., Millaire A., Desnos M., Schwartz K., Hainque B., Komajda M. Circulation 109:3258-3258(2004)
[24]	"Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy." Erdmann J., Daehmlow S., Wischke S., Senyuva M., Werner U., Raible J., Tanis N., Dyachenko S., Hummel M., Hetzer R., Regitz-Zagrosek V. Clin. Genet. 64:339-349(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS CMH4 LYS-258; TRP-282; ARG-507; TRP-523; ARG-566; PRO-668; VAL-833 AND ILE-1115, VARIANTS GLY-236 AND GLN-326.
[25]	"The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands." Alders M., Jongbloed R., Deelen W., van den Wijngaard A., Doevendans P., Ten Cate F., Regitz-Zagrosek V., Vosberg H.-P., van Langen I., Wilde A., Dooijes D., Mannens M. Eur. Heart J. 24:1848-1853(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS CMH4 SER-161; LYS-258; ASN-605; THR-833; TRP-834 AND THR-1131.
[26]	"A novel missense mutation in the myosin binding protein-C gene is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients." Konno T., Shimizu M., Ino H., Matsuyama T., Yamaguchi M., Terai H., Hayashi K., Mabuchi T., Kiyama M., Sakata K., Hayashi T., Inoue M., Kaneda T., Mabuchi H. J. Am. Coll. Cardiol. 41:781-786(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT CMH4 GLN-820.
[27]	"Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden." Moerner S., Richard P., Kazzam E., Hellman U., Hainque B., Schwartz K., Waldenstroem A. J. Mol. Cell. Cardiol. 35:841-849(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS CMH4 SER-237; HIS-668 AND THR-833, VARIANTS GLN-326 AND MET-896.
[28]	"Genetic and phenotypic characterization of mutations in myosin-binding protein C (MYBPC3) in 81 families with familial hypertrophic cardiomyopathy: total or partial haploinsufficiency." Andersen P.S., Havndrup O., Bundgaard H., Larsen L.A., Vuust J., Pedersen A.K., Kjeldsen K., Christiansen M. Eur. J. Hum. Genet. 12:673-677(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS CMH4 ASN-228; LYS-258; LYS-813 DEL AND THR-833.
[29]	"Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy." Van Driest S.L., Vasile V.C., Ommen S.R., Will M.L., Tajik A.J., Gersh B.J., Ackerman M.J. J. Am. Coll. Cardiol. 44:1903-1910(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS CMH4 ARG-5; LEU-219; ILE-256; LYS-258; HIS-458; ARG-490; GLN-495; TRP-502; GLN-542; VAL-604; ASN-605; LEU-608; CYS-733; ASN-770; ARG-792; HIS-810; LYS-811 DEL; THR-833; GLU-998; ARG-998; ILE-1113 AND THR-1131, VARIANTS MET-158; GLY-236; GLN-326; TRP-382; SER-416; ARG-507; MET-545 AND MET-896.
[30]	"Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy." Hayashi T., Arimura T., Itoh-Satoh M., Ueda K., Hohda S., Inagaki N., Takahashi M., Hori H., Yasunami M., Nishi H., Koga Y., Nakamura H., Matsuzaki M., Choi B.Y., Bae S.W., You C.W., Han K.H., Park J.E. , Knoell R., Hoshijima M., Chien K.R., Kimura A. J. Am. Coll. Cardiol. 44:2192-2201(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GLY-236.
[31]	"Mutations profile in Chinese patients with hypertrophic cardiomyopathy." Song L., Zou Y., Wang J., Wang Z., Zhen Y., Lou K., Zhang Q., Wang X., Wang H., Li J., Hui R. Clin. Chim. Acta 351:209-216(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS CMH4 LYS-258; ARG-263; SER-417; HIS-669 AND ASP-759.
[32]	"Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling." Ingles J., Doolan A., Chiu C., Seidman J., Seidman C., Semsarian C. J. Med. Genet. 42:E59-E59(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS CMH4 HIS-273; TRP-502 AND GLN-542, VARIANT GLN-326.
[33]	"Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene." Ehlermann P., Weichenhan D., Zehelein J., Steen H., Pribe R., Zeller R., Lehrke S., Zugck C., Ivandic B.T., Katus H.A. BMC Med. Genet. 9:95-95(2008) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS CMH4 LYS-258; CYS-272; VAL-336; GLN-495; GLN-502; SER-957 AND ILE-958.
[34]	"Shared genetic causes of cardiac hypertrophy in children and adults." Morita H., Rehm H.L., Menesses A., McDonough B., Roberts A.E., Kucherlapati R., Towbin J.A., Seidman J.G., Seidman C.E. N. Engl. J. Med. 358:1899-1908(2008) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS CMH4 GLU-278; ARG-490; GLY-495; GLN-502; TRP-502; ASN-605; SER-1028 AND ARG-1248, VARIANTS MET-158; GLY-236; GLN-326; MET-896 AND TRP-1002.
[35]	"Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy." Hershberger R.E., Norton N., Morales A., Li D., Siegfried J.D., Gonzalez-Quintana J. Circ. Cardiovasc. Genet. 3:155-161(2010) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS CMD1MM ARG-490; THR-833 AND PHE-1264.
[36]	"Sarcomere gene mutations in isolated left ventricular noncompaction cardiomyopathy do not predict clinical phenotype." Probst S., Oechslin E., Schuler P., Greutmann M., Boye P., Knirsch W., Berger F., Thierfelder L., Jenni R., Klaassen S. Circ. Cardiovasc. Genet. 4:367-374(2011) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS LVNC10 ARG-490 AND LEU-873.
[37]	"Autosomal recessive transmission of MYBPC3 mutation results in malignant phenotype of hypertrophic cardiomyopathy." Wang Y., Wang Z., Yang Q., Zou Y., Zhang H., Yan C., Feng X., Chen Y., Zhang Y., Wang J., Zhou X., Ahmad F., Hui R., Song L. PLoS ONE 8:E67087-E67087(2013) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT CMH4 VAL-490.
+	Additional computationally mapped references.

Web resources

GeneReviews

NIEHS-SNPs

Cross-references

Sequence databases

EMBL
GenBank
DDBJ

X84075 mRNA. Translation: CAA58882.1.
Y10129 Genomic DNA. Translation: CAA71216.1.
U91629 Genomic DNA. Translation: AAC04620.1.
AY518390 Genomic DNA. Translation: AAR89909.1.
GU324918 Genomic DNA. Translation: ADL14489.1.
AC090582 Genomic DNA. No translation available.
BC136543 mRNA. Translation: AAI36544.1.
BC136546 mRNA. Translation: AAI36547.1.
BC142685 mRNA. Translation: AAI42686.1.
BC151211 mRNA. Translation: AAI51212.1.
S80778 mRNA. Translation: AAB35662.1.

PIR

S55050.

RefSeq

NP_000247.2. NM_000256.3.

UniGene

Hs.524906.

3D structure databases

PDBe
RCSB PDB
PDBj

Entry	Method	Resolution (Å)	Chain	Positions	PDBsum
1GXE	NMR	-	A	641-770	[»]
1PD6	NMR	-	A	358-451	[»]
2AVG	NMR	-	A	151-260	[»]
2K1M	NMR	-	A	2-96	[»]
2V6H	X-ray	1.55	A	151-258	[»]
3CX2	X-ray	1.30	A	151-258	[»]

ProteinModelPortal

Q14896.

SMR

Q14896. Positions 2-96, 151-258, 319-353, 358-1168, 1181-1271.

ModBase

Search...

MobiDB

Search...

Protein-protein interaction databases

BioGrid

110692. 9 interactions.

IntAct

Q14896. 3 interactions.

MINT

MINT-6174801.

STRING

9606.ENSP00000382193.

PTM databases

PhosphoSite

Q14896.

Polymorphism databases

DMDM

116242668.

2D gel databases

UCD-2DPAGE

Q14896.

Proteomic databases

PaxDb

Q14896.

PRIDE

Q14896.

Protocols and materials databases

StructuralBiologyKnowledgebase

Search...

Genome annotation databases

Ensembl

ENST00000256993; ENSP00000256993; ENSG00000134571.
ENST00000545968; ENSP00000442795; ENSG00000134571.

GeneID

4607.

KEGG

hsa:4607.

UCSC

uc021qir.1. human.

Organism-specific databases

CTD

4607.

GeneCards

GC11M048799.

HGNC

HGNC:7551. MYBPC3.

HPA

HPA040147.
HPA043898.

MIM

115197. phenotype.
600958. gene.
615396. phenotype.

neXtProt

NX_Q14896.

Orphanet

154. Familial isolated dilated cardiomyopathy.
155. Familial isolated hypertrophic cardiomyopathy.
54260. Left ventricular noncompaction.

PharmGKB

PA31351.

GenAtlas

Search...

Phylogenomic databases

eggNOG

NOG12793.

HOGENOM

HOG000220906.

HOVERGEN

HBG052560.

KO

K12568.

OMA

EIQMSGS.

OrthoDB

EOG7WX07H.

TreeFam

TF351819.

Enzyme and pathway databases

Reactome

REACT_17044. Muscle contraction.

Gene expression databases

ArrayExpress

Q14896.

Bgee

Q14896.

CleanEx

HS_MYBPC3.

Genevestigator

Q14896.

Family and domain databases

Gene3D

2.60.40.10. 11 hits.

InterPro

IPR003961. Fibronectin_type3.
IPR007110. Ig-like_dom.
IPR013783. Ig-like_fold.
IPR013098. Ig_I-set.
IPR003599. Ig_sub.
IPR003598. Ig_sub2.
[Graphical view]

Pfam

PF00041. fn3. 3 hits.
PF07679. I-set. 8 hits.
[Graphical view]

SMART

SM00060. FN3. 3 hits.
SM00409. IG. 7 hits.
SM00408. IGc2. 1 hit.
[Graphical view]

SUPFAM

SSF49265. SSF49265. 2 hits.

PROSITE

PS50853. FN3. 3 hits.
PS50835. IG_LIKE. 6 hits.
[Graphical view]

ProtoNet

Search...

Other

ChiTaRS

MYBPC3. human.

EvolutionaryTrace

Q14896.

GeneWiki

Myosin_binding_protein_C,_cardiac.

GenomeRNAi

4607.

NextBio

17732.

PRO

Q14896.

SOURCE

Search...

Entry information

Entry name

MYPC3_HUMAN

Accession

Primary (citable) accession number: Q14896
Secondary accession number(s): A5PL00 , Q16410, Q6R2F7, Q9UE27, Q9UM53

Entry history

Integrated into UniProtKB/Swiss-Prot:	July 15, 1999
Last sequence update:	November 28, 2012
Last modified:	February 19, 2014
This is version 147 of the entry and version 4 of the sequence. [Complete history]

Entry status

Reviewed (UniProtKB/Swiss-Prot)

Annotation program

Chordata Protein Annotation Program

Disclaimer

Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.